Pediatric Transplant & Immunocompromised Host Infectious Diseases Programs

Pediatric Transplant & Immunocompromised Host Infectious Diseases Programs

  • About
  • Approach
  • Appointments
  • Services
  • Doctors

    • The Pediatric Transplant and Immunocompromised Host Infectious Diseases Programs provide inpatient and outpatient consultative care for immunocompromised children, who are at increased risk for infection. Our patients include solid organ and bone marrow transplant recipients, children undergoing chemotherapy for cancer treatment, children who are treated with immunosuppressive medications, and children with primary immunodeficiencies and acquired immunodeficiencies, such as HIV infection.

    We are closely affiliated with the U-M Health Transplant Center, which is one of the largest and most experienced centers for pediatric solid organ transplantation in the region. We also work closely with the Pediatric Blood & Marrow Transplantation Program and the Immuno-Hematology Comprehensive Program at C.S. Mott Children’s Hospital.

    Our Approach

    Our team, led by director Dr. Kengo Inagaki, provides state-of-the-art care to diagnose and treat infections in immunocompromised patients when they are in the hospital and follow-up outpatient care after they are discharged. We provide pre-transplant evaluation services to optimize approaches to assess risks for infections. We help to guide immunization strategies and other measures to prevent infections in the post-transplant period.

    Appointment Information

    Providers in our program see patients in our outpatient clinic who are referred by their primary or subspecialty physicians.

    Services

    We provide consultative care in the hospital and in our outpatient clinic to prevent, diagnose, and treat infections in children with a wide variety of immunocompromising conditions. Examples include:

    • Solid organ transplant recipients
    • Bone marrow and hematopoietic stem cell transplant recipients
    • Children with bone marrow suppression due to cancer chemotherapy
    • Children treated with immunomodulatory therapy for autoimmune/autoinflammatory diseases
    • Children with primary immunodeficiencies
    • Children with HIV infection

    On an institutional basis, team members provide expertise to guide the development of policies for prevention and treatment of infections that can occur in immunocompromised children.

    Doctors

     Search for a U-M Health doctor     Kengo Inagaki, MD

    Kengo Inagaki, MD

    Clinical Professor

    Pediatric Infectious Disease, Pediatrics

    labcoat

    Kay Eileen Leopold, MD

    Clinical Assistant Professor

    Pediatric Infectious Disease, Pediatrics

    Alison Christine Tribble, MD

    Clinical Associate Professor

    Pediatric Infectious Disease, Pediatrics

    Kavita Shanker Warrier, MD

    Kavita Shanker Warrier, MD

    Clinical Assistant Professor

    Pediatric Infectious Disease, Pediatrics

    Michigan Photo

    Michael Edmund Watson, MD, PhD

    Clinical Associate Professor

    Pediatric Infectious Disease, Pediatrics

    Jason Brice Weinberg, MD

    Jason Brice Weinberg, MD

    Associate Professor

    Pediatric Infectious Disease, Pediatrics

    Providers

     Search for a U-M Health provider     labcoat

    Ann Catherine Melling, PA-C

    Physician Assistant

    Physician Assistant

    labcoat

    Danielle VanDamme, NP

    Advanced Practice Nurse

    Nurse Practitioner